Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2009-04-21 | Ronald Prentki has served as our President, Chief Executive Officer and Director since July 2008. Previously he was President of Easton Healthcare Ventures, LLC, a business development and consulting company he founded in 2005. Mr. Prentki served as President and Director from 1998 to 2005 for Progenics Pharmaceuticals, Inc., a biopharmaceutical company focusing on the development of products for HIV, cancer and supportive care. Prior to joining Progenics, Mr. Prentki served as Vice-President of Business Development for Sanofi Pharma and Sterling Drug, and Director of Cardiovascular Products and Manager of Anti-Cancer Products for Bristol-Myers Squibb. |
Data sourced from SEC filings. Last updated: 2025-07-01